**Exhibit 99.1**

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Bio-Technology General Corp.(the “Company”) on Form 10-K for the year ended December 31, 2002 as filed withthe Securities and Exchange Commission on the date hereof (the “Report”), I,Sim Fass, Chief Executive Officer of the Company, certify, pursuant to 18U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002,that:

 

(1)           The Report fullycomplies with the requirements of section 13(a) or 15(d) of the SecuritiesExchange Act of 1934; and

 

(2)           The informationcontained in the Report fairly presents, in all material respects, thefinancial condition and results of operations of the Company.

 

 
|   | By:                     | /s/ Sim Fass |   |
|--------|-------------------------|--------------|--------|
|   | Sim Fass                |
|   | Chief Executive Officer |
|   | March 31, 2003          |

 

A signed original of this written statement required by Section 906 hasbeen provided to Bio-Technology General Corp. and will be retained by Bio-TechnologyGeneral Corp. and furnished to the Securities and Exchange Commission or itsstaff upon request.

 

----

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Bio-Technology General Corp.(the “Company”) on Form 10-K for the year ended December 31, 2002 as filed withthe Securities and Exchange Commission on the date hereof (the “Report”), I,Whitney K. Stearns, Jr., Senior Vice President—Chief Financial Officer andTreasurer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adoptedpursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1)           The Report fullycomplies with the requirements of section 13(a) or 15(d) of the SecuritiesExchange Act of 1934; and

 

(2)           The informationcontained in the Report fairly presents, in all material respects, thefinancial condition and results of operations of the Company.

 
|   | By:                                                               | /s/ Whitney K. Stearns, Jr. |   |
|--------|-------------------------------------------------------------------|-----------------------------|--------|
|   | Whitney K. Stearns, Jr.                                           |
|   | Senior Vice President—Chief Financial Officer  and Treasurer |
|   | March 31, 2003                                                    |

 

A signed original of this written statement required by Section 906 hasbeen provided to Bio-Technology General Corp. and will be retained byBio-Technology General Corp. and furnished to the Securities and ExchangeCommission or its staff upon request.

 

2

----

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Bio-Technology General Corp.(the “Company”) on Form 10-K for the year ended December 31, 2002 as filed withthe Securities and Exchange Commission on the date hereof (the “Report”), I,Yehuda Sternlicht, Vice President—Chief Accounting Officer of the Company,certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of theSarbanes-Oxley Act of 2002, that:

 

(1)           The Report fullycomplies with the requirements of section 13(a) or 15(d) of the SecuritiesExchange Act of 1934; and

 

(2)           The informationcontained in the Report fairly presents, in all material respects, thefinancial condition and results of operations of the Company.

 
|   | By:                                          | /s/ Yehuda Sternlicht |   |
|--------|----------------------------------------------|-----------------------|--------|
|   | Yehuda Sternlicht                            |
|   | Vice President—Chief Accounting Officer |
|   | March 31, 2003                               |

 

A signed original of this written statement required by Section 906 hasbeen provided to Bio-Technology General Corp. and will be retained byBio-Technology General Corp. and furnished to the Securities and ExchangeCommission or its staff upon request.

 

3

----